AKI in Patients Receiving Immune Checkpoint Inhibitors
- 2 May 2019
- journal article
- editorial
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 14 (7) , 1077-1079
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experienceJournal for ImmunoTherapy of Cancer, 2019
- Renal toxicities associated with pembrolizumabClinical Kidney Journal, 2018
- Cardiorenal complications of immune checkpoint inhibitorsNature Reviews Nephrology, 2018
- Nephrotoxicity of Cancer Immunotherapies: Past, Present and FutureJournal of the American Society of Nephrology, 2018
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice GuidelineJournal of Clinical Oncology, 2018
- Immune-Related Adverse Events Associated with Immune Checkpoint BlockadeNew England Journal of Medicine, 2018
- Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitorsKidney International, 2016
- Association of Acute Interstitial Nephritis With Programmed Cell Death 1 Inhibitor Therapy in Lung Cancer PatientsAmerican Journal of Kidney Diseases, 2016
- MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor CellsJNCI: Journal of the National Cancer Institute, 2013
- Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and PromotionScience, 2011